RxDoctor Payments Data

Calvin Choi, MD

Interventional Cardiology · Jacksonville, FLNPI 1710076724

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (28.7%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. 7 manufacturers reported payments, led by E.r. Squibb & Sons, L.L.C. at 57.7% of the total. Reporting peaked in 2022 at $7,054 and has fallen 64.6% since, to $2,496 in 2025.

$11,745in general payments, 2019–2025

Across 42 payments — averaging $279.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • E.r. Squibb & Sons, L.L.C.$7K
  • Abbott$3K
  • Boston Scientific$869
  • Edwards Lifesciences$773
  • Medtronic$284
  • Abiomed$279
  • plus $256 from 1 others
$19in research payments, 2019–2025

Across 1 payment — averaging $18.98 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Abbott$19

What the payments were for

  • Consulting fees$2,40020%
  • Speaking & faculty fees$3,00026%
  • Travel & lodging$3,37629%
  • Food & beverage$2,96825%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,745 in reported general payments places this provider in the 60th percentile of 623 interventional cardiology providers in Florida.

See all interventional cardiology providers in Florida →

Medicare billing

Part B allowed, 2024
$86,149
Medicare patients
201
Services billed
494

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban20$19,700
Prasugrel Hcl16$1,280
ClopidogrelClopidogrel Bisulfate21$231
Metoprolol Succinate13$161
Amlodipine Besylate14$156
Atorvastatin Calcium12$154
Carvedilol11$79

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in Jacksonville

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →